Duan Lewei, Kawatkar Aniket A
Biostatistician in the Department of Research and Evaluation for Kaiser Permanente Southern California in Pasadena.
Research Scientist in the Department of Research and Evaluation for Kaiser Permanente Southern California in Pasadena.
Perm J. 2018;22:17-132. doi: 10.7812/TPP/17-132.
Many patients with ductal carcinoma in situ (DCIS) receive treatment that is too extensive.
To take a holistic approach in comparing the effectiveness in cancer prevention between mastectomy and breast-conserving surgery (BCS) for patients with DCIS.
Female Kaiser Permanente Southern California members who underwent surgery for treatment of single primary DCIS from 2004 to 2014 were identified by the Kaiser Permanente Southern California cancer registry and HealthConnect database.
Two-stage residual inclusion with the surgeon's preference of surgical procedure type as the instrumental variable was used to examine the effect of surgical choice on DCIS recurrence, breast cancer progression, and other cancer progression. Traditional Cox proportional hazards models were used for comparison.
Of qualified subjects, 72.2% underwent BCS and 27.8% underwent mastectomy. Patients were likelier to receive BCS if their surgeon preferred to perform BCS in the past 5 years (odds ratio = 1.02, 95% confidence interval = 1.02-1.03). Although traditional Cox proportional hazards models suggested an association between BCS and higher risk of DCIS recurrence, no significant effect was observed when we adjusted for endogeneity. Neither model showed significant differences between mastectomy and BCS in progression of any cancer.
No significant benefit was observed with a more aggressive surgical procedure in preventing DCIS recurrence or cancer progression in a diverse population. Many patients with DCIS could benefit from BCS with preservation of their body image. Breast conservation followed-up with cancer surveillance is a rational approach to ensure affordable, effective care for patients with DCIS.
许多导管原位癌(DCIS)患者接受了过度的治疗。
采用整体方法比较乳房切除术和保乳手术(BCS)对DCIS患者预防癌症的有效性。
通过南加州凯撒医疗集团癌症登记处和健康连接数据库,识别出2004年至2014年期间因治疗单一原发性DCIS而接受手术的南加州凯撒医疗集团女性成员。
以外科医生对手术类型的偏好作为工具变量,采用两阶段残差纳入法,研究手术选择对DCIS复发、乳腺癌进展和其他癌症进展的影响。使用传统的Cox比例风险模型进行比较。
在符合条件的受试者中,72.2%接受了保乳手术,27.8%接受了乳房切除术。如果外科医生在过去5年中更倾向于进行保乳手术,患者接受保乳手术的可能性更大(优势比=1.02,95%置信区间=1.02-1.03)。尽管传统的Cox比例风险模型表明保乳手术与DCIS复发风险较高之间存在关联,但在调整内生性后未观察到显著影响。两种模型均未显示乳房切除术和保乳手术在任何癌症进展方面存在显著差异。
在不同人群中,更积极的手术方法在预防DCIS复发或癌症进展方面未观察到显著益处。许多DCIS患者可从保乳手术中受益,同时保留身体形象。保乳手术结合癌症监测随访是确保为DCIS患者提供经济有效治疗的合理方法。